Charlotte J. Haug, M bitartrate .D., Ph.D.1 The retractions came only months after BioMed Central, an open-access publisher owned by Springer, retracted 43 content for the same reason. How is it possible to fake peer review? Moon, who studies medicinal plants, had set up a straightforward procedure. He gave journals recommendations for peer reviewers for his manuscripts, providing them with e-mail and titles addresses. But these addresses were ones he created, so the requests to review went directly to him or his co-workers. The fallout from Moon’s confession: 28 articles in various journals published by Informa were retracted, and one editor resigned.
This annual publication provides the only comprehensive report on all AIDS vaccine scientific trial activity worldwide. AMERICA, United Kingdom, Sweden and Peru started new trials in 2006 aswell. A number of these trials were sponsored by brand-new research groups, like the Karolinska Institute in Sweden, St. George’s University of London and the Moscow Institute of Immunology. Related StoriesNew research may offer approaches for developing toxoplasma-inactivated vaccineSinovac Dalian receives approval to start human medical trials of varicella vaccine candidateBasic analysis for developing toxoplasma vaccine underwayAll of the new trials that started last year were either Phase I or Stage I/II trials made to evaluate the basic safety and immunogenicity of the applicant vaccines.